Goldfrank's Toxicologic Emergencies, 11th Edition

Complete eTextbook Content:
Chapter 1: Historical Principles and Perspectives
Chapter 2: Toxicologic Misfortunes and Catastrophes in History
PART A: THE GENERAL APPROACH TO THE PATIENT
Case Study 1
Chapter 3: Initial Evaluation of The Patient: Vital Signs and Toxic Syndromes
Case Study 2
Chapter 4: Principles of Managing the Acutely Poisoned or Overdosed Patient
Chapter SC1: Principles of Antidote Stocking
Chapter 5: Techniques Used to Prevent Gastrointestinal Absorption
Chapter SC2: Decontamination Principles: Prevention of Dermal, Ophthalmic, and Inhalational Absorption
Chapter A1: Activated Charcoal
Chapter A2: Whole-Bowel Irrigation and Other Intestinal Evacuants
Chapter 6: Principles and Techniques Applied to Enhance Elimination
Chapter 7: Laboratory Principles
Chapter 8: Principles of Diagnostic Imaging
Chapter 9: Pharmacokinetic and Toxicokinetic Principles
PART B: THE FUNDAMENTAL PRINCIPLES OF MEDICAL TOXICOLOGY
SECTION I: BIOCHEMICAL AND MOLECULAR CONCEPTS
Chapter 10: Chemical Principles
Chapter 11: Biochemical and Metabolic Principles
Chapter 12: Fluid, Electrolyte, and Acid–Base Principles
Chapter 13: Neurotransmitters and Neuromodulators
Chapter 14: Withdrawal Principles
SECTION II: PATHOPHYSIOLOGIC BASIS: ORGAN SYSTEMS
Case Study 3
Chapter 15: Cardiologic Principles I: Electrophysiologic and Electrocardiographic Principles
Chapter 16: Cardiologic Principles II: Hemodynamics
Case Study 4
Chapter 17: Dermatologic Principles
Chapter SC3: Transdermal Toxicology
Chapter 18: Gastrointestinal Principles
Chapter 19: Genitourinary Principles
Chapter 20: Hematologic Principles
Chapter 21: Hepatic Principles
Case Study 5
Chapter 22: Neurologic Principles
Chapter 23: Oncologic Principles
Chapter 24: Ophthalmic Principles
Chapter 25: Otolaryngologic Principles
Chapter 26: Psychiatric Principles
Chapter SC4: Patient Violence
Chapter 27: Renal Principles
Chapter 28: Respiratory Principles
Chapter 29: Thermoregulatory Principles
SECTION III: SPECIAL POPULATIONS
Chapter 30: Reproductive and Perinatal Principles
Chapter 31: Pediatric Principles
Case Study 6
Chapter 32: Geriatric Principles
PART C: THE CLINICAL BASIS OF MEDICAL TOXICOLOGY
SECTION I
A: ANALGESICS AND ANTIINFLAMMATORY MEDICATIONS
Chapter 33: Acetaminophen
Chapter A3: N-Acetylcysteine
Chapter 34: Colchicine, Podophyllin, and the Vinca Alkaloids
Chapter 35: Nonsteroidal Antiinflammatory Drugs
Chapter 36: Opioids
Chapter A4: Opioid Antagonists
Chapter SC5: Internal Concealment of Xenobiotics
Chapter SC6: Prevention, Treatment, and Harm Reduction Approaches to Opioid Overdoses
Chapter 37: Salicylates
Chapter A5: Sodium Bicarbonate
B: FOOD, DIET, AND NUTRITION
Chapter 38: Botulism
Chapter A6: Botulinum Antitoxin
Chapter 39: Food Poisoning
Chapter 40: Dieting Xenobiotics and Regimens
Chapter 41: Athletic Performance Enhancers
Chapter 42: Essential Oils
Chapter 43: Plant- and Animal-Derived Dietary Supplements
Chapter 44: Vitamins
Chapter 45: Iron
Chapter A7: Deferoxamine
C: PHARMACEUTICALS
Chapter 46: Pharmaceutical Additives
Chapter 47: Antidiabetics and Hypoglycemics/Antiglycemics
Chapter A8: Dextrose (D-Glucose)
Chapter A9: Octreotide
Chapter 48: Antiepileptics
Chapter A10: L-Carnitine
Case Study 7
Chapter 49: Antihistamines and Decongestants
Chapter A11: Physostigmine Salicylate
Chapter 50: Chemotherapeutics
Chapter 51: Methotrexate, 5-Fluorouracil, and Capecitabine
Chapter A12: Folates: Leucovorin (Folinic Acid) and Folic Acid
Chapter A13: Glucarpidase (Carboxypeptidase G2)
Chapter A14: Uridine Triacetate
Chapter SC7: Intrathecal Administration of Xenobiotics
Chapter SC8: Extravasation of Xenobiotics
Chapter 52: Antimigraine Medications
Chapter 53: Thyroid and Antithyroid Medications
D: ANTIMICROBIALS
Chapter 54: Antibacterials, Antifungals, and Antivirals
Chapter 55: Antimalarials
Chapter 56: Antituberculous Medications
Chapter A15: Pyridoxine
E: CARDIOPULMONARY MEDICATIONS
Chapter 57: Antidysrhythmics
Chapter A16: Magnesium
Chapter 58: Antithrombotics
Chapter A17: Prothrombin Complex Concentrates and Direct Oral Anticoagulant Antidotes
Chapter A18: Vitamin K1
Chapter A19: Protamine
Case Study 8
Chapter 59: β-Adrenergic Antagonists
Chapter A20: Glucagon
Chapter 60: Calcium Channel Blockers
Chapter A21: High-Dose Insulin
Chapter 61: Miscellaneous Antihypertensives and Pharmacologically Related Agents
Chapter 62: Cardioactive Steroids
Chapter A22: Digoxin-Specific Antibody Fragments
Chapter 63: Methylxanthines and Selective β2-Adrenergic Agonists
F: ANESTHETICS AND RELATED MEDICATIONS
Chapter 64: Local Anesthetics
Chapter A23: Lipid Emulsion
Chapter 65: Inhalational Anesthetics
Chapter 66: Neuromuscular Blockers
Chapter A24: Dantrolene Sodium
G: PSYCHOTROPIC MEDICATIONS
Chapter 67: Antipsychotics
Chapter 68: Cyclic Antidepressants
Chapter 69: Serotonin Reuptake Inhibitors and Atypical Antidepressants
Chapter 70: Lithium
Chapter 71: Monoamine Oxidase Inhibitors
Chapter 72: Sedative–Hypnotics
Chapter A25: Flumazenil
H: SUBSTANCES OF ABUSE
Chapter 73: Amphetamines
Chapter 74: Cannabinoids
Chapter 75: Cocaine
Chapter A26: Benzodiazepines
Chapter 76: Ethanol
Chapter A27: Thiamine Hydrochloride
Chapter 77: Alcohol Withdrawal
Chapter 78: Disulfiram and Disulfiramlike Reactions
Chapter 79: Hallucinogens
Chapter 80: γ-Hydroxybutyric Acid (γ-Hydroxybutyrate)
Chapter 81: Inhalants
Chapter 82: Nicotine
Chapter 83: Phencyclidine and Ketamine
I: METALS
Case Study 9
Chapter 84: Aluminum
Chapter 85: Antimony
Chapter 86: Arsenic
Chapter A28: Dimercaprol (British Anti-Lewisite or BAL)
Chapter 87: Bismuth
Chapter 88: Cadmium
Chapter 89: Cesium
Chapter 90: Chromium
Chapter 91: Cobalt
Chapter 92: Copper
Chapter 93: Lead
Chapter A29: Succimer (2,3-Dimercaptosuccinic Acid) and Dmps (2,3-Dimercapto-1-Propanesulfonic Acid)
Chapter A30: Edetate Calcium Disodium (CaNa2Edta)
Chapter 94: Manganese
Chapter 95: Mercury
Chapter 96: Nickel
Chapter 97: Selenium
Chapter 98: Silver
Chapter 99: Thallium
Chapter A31: Prussian Blue
Chapter 100: Zinc
J: HOUSEHOLD PRODUCTS
Chapter 101: Antiseptics, Disinfectants, and Sterilants
Chapter 102: Camphor and Moth Repellents
Chapter 103: Caustics
Chapter 104: Hydrofluoric Acid and Fluorides
Chapter A32: Calcium
Chapter 105: Hydrocarbons
Case Study 10
Chapter 106: Toxic Alcohols
Chapter A33: Fomepizole
Chapter A34: Ethanol
Chapter SC9: Diethylene Glycol
K: PESTICIDES
Case Study 11
Chapter 107: Barium
Chapter 108: Fumigants
Chapter 109: Herbicides
Chapter 110: Insecticides: Organic Phosphorus Compounds and Carbamates
Chapter A35: Atropine
Chapter A36: Pralidoxime
Chapter 111: Insecticides: Organic Chlorines, Pyrethrins/Pyrethroids, and Insect Repellents
Chapter 112: Phosphorus
Chapter 113: Sodium Monofluoroacetate and Fluoroacetamide
Chapter 114: Strychnine
L: NATURAL TOXINS AND ENVENOMATIONS
Chapter 115: Arthropods
Chapter A37: Antivenom: Spider
Chapter A38: Antivenom: Scorpion
Chapter 116: Marine Envenomations
Chapter 117: Mushrooms
Chapter 118: Plants
Chapter 119: Native (US) Venomous Snakes and Lizards
Chapter A39: Antivenom for North American Venomous Snakes (Crotaline and Elapid)
Chapter SC10: Exotic Nonnative Snake Envenomations
M: OCCUPATIONAL AND ENVIRONMENTAL TOXINS
Case Study 12
Chapter 120: Smoke Inhalation
Case Study 13
Chapter 121: Simple Asphyxiants and Pulmonary Irritants
Chapter 122: Carbon Monoxide
Chapter A40: Hyperbaric Oxygen
Chapter 123: Cyanide and Hydrogen Sulfide
Chapter A41: Hydroxocobalamin
Chapter A42: Nitrites (Amyl and Sodium) and Sodium Thiosulfate
Chapter 124: Methemoglobin Inducers
Chapter A43: Methylene Blue
Chapter 125: Nanotoxicology
N: DISASTER PREPAREDNESS
Chapter 126: Chemical Weapons
Chapter 127: Biological Weapons
Chapter 128: Radiation
Chapter A44: Potassium Iodide
Chapter A45: Pentetic Acid or Pentetate (Zinc or Calcium) Trisodium (DTPA)
PART D: POPULATION HEALTH
SECTION I: POISON CONTROL CENTERS, HEALTH SYSTEMS, AND EPIDEMIOLOGY
Chapter 129: Poison Prevention and Education
Chapter 130: Poison Control Centers and Poison Epidemiology
Chapter 131: Principles of Occupational Toxicology: Diagnosis and Control
Chapter 132: Hazardous Materials Incident Response
Chapter 133: Risk Assessment and Risk Communication
Case Study 14
Chapter 134: Medication Safety and Adverse Drug Events
Chapter 135: Drug Development, Adverse Drug Events, and Postmarketing Surveillance
Chapter 136: International Perspectives on Medical Toxicology
Chapter 137: Principles of Epidemiology and Research Design
SECTION II: LEGAL ASPECTS OF TOXICOLOGY
Chapter 138: Risk Management and Legal Principles
Chapter 139: Medicolegal Interpretive Toxicology
Chapter SC11: Assessment of Ethanol-Induced Impairment
Chapter 140: Postmortem Toxicology
Chapter SC12: Organ Procurement From Poisoned Patients

Click here to download the sample files

Name: Goldfrank’s Toxicologic Emergencies, 11th Edition
Author: Lewis Nelson, Robert Hoffman, Mary Ann Howland, Neal Lewin, Lewis Goldfrank, Silas W Smith
Edition: 11th
ISBN-10: 1259859614
ISBN-13: 978-1259859618
Type: eTextbook

This is a eBook for the actual textbook of Goldfrank’s Toxicologic Emergencies, 11th Edition, by Lewis Nelson, Robert Hoffman, Mary Ann Howland, Neal Lewin, Lewis Goldfrank, Silas W Smith.

eTextbook comes in pdf format which can work under all PC based windows operating system and Mac, Linux OS, Iphone, Ipad, Android etc…

It saves to your hard-drive and can be burned to CD-ROM. All pages are printable.

It is exactly same as the actual hardbook. And it is Color Version.

File Includes:

1) A COMPLETE eBook 2101 Pages), with all single page and Chapters, Color Version. Same as the original textbook. Comes with PDF file format. Can be read by Adobe Reader.

It is only computer file/s, I will not ship hard copy. The file can be downloaded instantly after the payment has been made.

Satisfaction guaranteed. Files are Checked before upload. All are good and pure!